159 related articles for article (PubMed ID: 35850672)
1. Cross-cultural differences in men on active surveillance' anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance study.
Dordoni P; Remmers S; Valdagni R; Bellardita L; De Luca L; Badenchini F; Marenghi C; Roobol MJ; Venderbos LDF
BMC Urol; 2022 Jul; 22(1):110. PubMed ID: 35850672
[TBL] [Abstract][Full Text] [Related]
2. Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance.
Alvisi MF; Repetto C; Rancati T; Badenchini F; Magnani T; Marenghi C; Villa S; Nicolai N; Salvioni R; Avuzzi B; Valdagni R; Bellardita L;
Tumori; 2018 Jun; 104(3):172-178. PubMed ID: 28623635
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.
Venderbos LD; van den Bergh RC; Roobol MJ; Schröder FH; Essink-Bot ML; Bangma CH; Steyerberg EW; Korfage IJ
Psychooncology; 2015 Mar; 24(3):348-54. PubMed ID: 25138075
[TBL] [Abstract][Full Text] [Related]
4. Supporting Patients With Untreated Prostate Cancer on Active Surveillance: What Causes an Increase in Anxiety During the First 10 Months?
Alvisi MF; Dordoni P; Rancati T; Avuzzi B; Nicolai N; Badenchini F; De Luca L; Magnani T; Marenghi C; Menichetti J; Silvia V; Fabiana Z; Roberto S; Riccardo V; Lara B;
Front Psychol; 2020; 11():576459. PubMed ID: 33363494
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.
Bul M; van den Bergh RC; Zhu X; Rannikko A; Vasarainen H; Bangma CH; Schröder FH; Roobol MJ
BJU Int; 2012 Dec; 110(11):1672-7. PubMed ID: 22928973
[TBL] [Abstract][Full Text] [Related]
6. Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients.
Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
Eur Urol Oncol; 2019 Sep; 2(5):483-489. PubMed ID: 31411970
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.
Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A
BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485
[TBL] [Abstract][Full Text] [Related]
8. Investigating the psychological impact of active surveillance or active treatment in newly diagnosed favorable-risk prostate cancer patients: A 9-month longitudinal study.
Ruane-McAteer E; Porter S; O'Sullivan J; Dempster M; Prue G
Psychooncology; 2019 Aug; 28(8):1743-1752. PubMed ID: 31243872
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Cancer Specific Anxiety in Men Undergoing Active Surveillance of Prostate Cancer: Findings from a Large Prospective Cohort.
Marzouk K; Assel M; Ehdaie B; Vickers A
J Urol; 2018 Dec; 200(6):1250-1255. PubMed ID: 29886089
[TBL] [Abstract][Full Text] [Related]
10. Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients.
Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
Eur Urol Oncol; 2018 Aug; 1(3):231-237. PubMed ID: 31102626
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between Intolerance of Uncertainty and Anxiety in Men on Active Surveillance for Prostate Cancer.
Tan HJ; Marks LS; Hoyt MA; Kwan L; Filson CP; Macairan M; Lieu P; Litwin MS; Stanton AL
J Urol; 2016 Jun; 195(6):1724-30. PubMed ID: 26872841
[TBL] [Abstract][Full Text] [Related]
12. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
13. Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols.
Kates M; Tosoian JJ; Trock BJ; Feng Z; Carter HB; Partin AW
BJU Int; 2015 Feb; 115(2):216-22. PubMed ID: 24904995
[TBL] [Abstract][Full Text] [Related]
14. Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer.
Venderbos LD; Roobol MJ; Bangma CH; van den Bergh RC; Bokhorst LP; Nieboer D; Godtman R; Hugosson J; van der Kwast T; Steyerberg EW
World J Urol; 2016 Feb; 34(2):253-60. PubMed ID: 26160006
[TBL] [Abstract][Full Text] [Related]
15. The association of cancer-specific anxiety with disease aggressiveness in men on active surveillance of prostate cancer.
Naha U; Freedland SJ; Abern MR; Moreira DM
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):335-340. PubMed ID: 32901094
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer.
van den Bergh RC; Korfage IJ; Borsboom GJ; Steyerberg EW; Essink-Bot ML
Qual Life Res; 2009 Oct; 18(8):1061-6. PubMed ID: 19669670
[TBL] [Abstract][Full Text] [Related]
17. Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial.
Wade J; Donovan J; Lane A; Davis M; Walsh E; Neal D; Turner E; Martin R; Metcalfe C; Peters T; Hamdy F; Kockelbergh R; Catto J; Paul A; Holding P; Rosario D; Kynaston H; Rowe E; Hughes O; Bollina P; Gillatt D; Doherty A; Gnanapragasam VJ; Paez E
BMJ Open; 2020 Sep; 10(9):e036024. PubMed ID: 32907896
[TBL] [Abstract][Full Text] [Related]
18. An evidence review of active surveillance in men with localized prostate cancer.
Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
[TBL] [Abstract][Full Text] [Related]
19. Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers.
Bokhorst LP; Alberts AR; Rannikko A; Valdagni R; Pickles T; Kakehi Y; Bangma CH; Roobol MJ;
Eur Urol; 2015 Nov; 68(5):814-21. PubMed ID: 26138043
[TBL] [Abstract][Full Text] [Related]
20. A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment.
Bokhorst LP; Valdagni R; Rannikko A; Kakehi Y; Pickles T; Bangma CH; Roobol MJ;
Eur Urol; 2016 Dec; 70(6):954-960. PubMed ID: 27329565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
